Results 21 to 30 of about 465 (123)
Laryngopharyngeal reflux in patients with reflux esophagitis
World Journal of Gastroenterology, 2008 To assess the prevalence of laryngopharyngeal reflux (LPR) in patients with reflux esophagitis and disclose factors contributing to the development of LPR.A total of 167 patients who proved to have reflux esophagitis by endoscopy were enrolled. They received laryngoscopy to grade the reflux findings for the diagnosis of LPR.
Yung-Chih, Lai +2 more
openaire +2 more sources
Characteristics and Management of Laryngopharyngeal Reflux in The Elderly : A Case Report
Journal of Community Medicine and Public Health ResearchLaryngopharyngeal reflux is a condition resulting from the retrograde flow of stomach acid through the distal esophagus into the laryngopharyngeal area. The prevalence of laryngo-pharyngeal reflux in the elderly population remains uncertain.
Wahyu Ikhsan, Aliyah Hidayati
doaj +1 more source
Laryngopharyngeal reflux: yesterday, today and tomorrow
Медицинский совет, 2016 The article tells about the results of a study of tonsils in patients with pharyngeal symptoms against a background of laryngopharyngeal reflux. An algorithm for the diagnosis and treatment of patients with chronic tonsillitis and laryngopharyngeal ...
S. Y. Kosyakov +3 more
doaj +1 more source
Российский журнал гастроэнтерологии, гепатологии, колопроктологииAim: to present the algorithm for differential diagnosis in patients with laryngopharyngeal symptoms, as well as diagnostic opportunities of the 24-hour hypopharyngeal-esophageal multichannel intraluminal pH-impedance monitoring using a special ...
A. V. Paraskevova +4 more
doaj +1 more source
Pregabalin Efficacy in Treatment of Chronic Neurogenic Cough
The Laryngoscope, EarlyView.The use of neuromodulators for chronic cough has increased; however, the choice of medication, dosing regimen, and duration are still unclear. This longitudinal study of 95 adults taking pregabalin, 75 mg twice daily, for CNC demonstrated 78% improvement or resolution of cough, 17% unchanged, 1% worse cough, with a mean of 6 weeks of therapy, and only ...
Jacqui Allen +3 more
wiley +1 more source
Laryngeal Cryotherapy for Neurogenic Cough: Safety, Feasibility, and Prospective Outcomes
The Laryngoscope, EarlyView.A prospective clinical trial investigated the safety and clinical outcomes of office‐based selective laryngeal cryotherapy for patients with refractory chronic cough. Patient were followed for 6 months posttreatment and had durable improvement in cough severity index and urge‐to‐cough scores and no serious long term adverse effects.
Shumon I. Dhar +6 more
wiley +1 more source
Brazilian Journal of Otorhinolaryngology, 2019 Introduction: Obstructive sleep apnea syndrome and laryngopharyngeal reflux are diseases with a high prevalence in the overall population; however, it remains unclear whether they are diseases with the same risk factors present in the same populations or
Fábio Azevedo Caparroz +6 more
doaj +1 more source
Cervical Inlet Patches in R‐CPD: An Unrecognized Predictor of Treatment Failure
The Laryngoscope, EarlyView.This retrospective cohort study identified cervical inlet patches (CIP) in 19.8% of patients undergoing cricopharyngeal botulinum toxin injection for R‐CPD. CIP presence and increasing age independently predicted failure to sustain a long‐term treatment response, suggesting that CIP may be an underrecognized factor in R‐CPD treatment durability ...
Andrew Geoffrey Tritter +2 more
wiley +1 more source
Laryngopharyngeal Reflux in Hypertrophic Laryngeal Diseases
Ear, Nose & Throat Journal, 2022 Objectives: To evaluate the characteristics of laryngopharyngeal reflux (LPR) in patients with different hypertrophic laryngeal diseases and to explore the relationship between LPR and these diseases. Methods: A retrospective analysis was performed.
Honglei Han MD +2 more
doaj +1 more source
Supraglottic Botulinum Toxin Injection Improves Symptoms of Laryngeal Sensory Dysfunction
The Laryngoscope, EarlyView.In this retrospective cohort of 80 patients with refractory laryngeal sensory symptoms, supraglottic botulinum toxin type A significantly improved Laryngeal Hypersensitivity Questionnaire, Reflux Symptom Index, and Cough Severity Index scores at a mean of 5.2 weeks, while Voice Handicap Index‐10 scores remained unchanged.
Daniel Novakovic +3 more
wiley +1 more source